|
Company Profile
Background
AtCor Medical is an
Australian-headquartered company with its Corporate,
Manufacturing, and R&D operations located in Sydney. An
American subsidiary, AtCor Medical Inc (USA), has its US
headquarters in Itasca, IL. AtCor Medical also has a
European representative office, and markets its products
through a network of national distributors in the major
countries of the world.
Mission
The mission of AtCor Medical is to develop products for
clinical use that can non-invasively assess the
physiological status and the functioning of the
cardiovascular system in humans. To do this, AtCor
Medical works with leading international medical
researchers in this field.
Products
AtCor Medical's innovative product range, the
SphygmoCor System, provides the following capabilities:
-
SphygmoCor CP Non-Invasive Aortic BP system, which
non-invasively derives the calibrated BP waveform at the
aortic root.
-
SphygmoCor CPV Pulse Wave Velocity system, which
measures the velocity of the BP pressure wave
between any two superficial artery sites (and so
gives a measure of arterial stiffness).
-
SphygmoCor CPVH Heart Rate Variability system, which
calculates the variability of the heart, including Valsalva and
Standing Manoeuvre tests.
-
SphygmoCor CPM
Non-Invasive Aortic BP Monitoring system, which
monitors the ascending aortic waveform continuously,
including real time trending of key central heart
function parameters.
The SphygmoCor CP system complements the traditional
cuff sphygmomanometer by non-invasively providing the
following previously unavailable central clinical
information:
-
Evaluation of arterial stiffness and its clinical
impact on the heart in increasing patient risk of heart
failure, stroke and myocardial ischaemia.
-
Coronary artery perfusion pressure throughout the
cardiac cycle, including during the critical period of
diastole when over 95% of subendocardial perfusion
occurs.
-
Left ventricular load, systolic “afterload”, and an
index of myocardial oxygen demand.
-
Pulse pressure in the ascending aorta which drives
cerebral blood flow - and hence a better indicator of
the risk of stroke.
-
Central systolic pressure (as seen by the baro-receptors),
often markedly different from the cuff value.
-
Ejection duration and other cardiac cycle timing
parameters.
-
A powerful index of subendocardial viability giving an
indication of cardiac reserve and exercise tolerance.
-
Efficacy of drug therapies on key central heart
function parameters.
Research Cooperation AtCor Medical is working with researchers in Australia,
Europe and the USA to extend the clinical applications
and the capabilities of its non-invasive cardiovascular
products. AtCor Medical seeks to work with researchers
and clinicians to develop new products, and enhance its
current products, in the medical market.
Marketing and Distribution In addition to United States operations, AtCor Medical
has an established distribution network in Europe and in
many Asia-Pacific countries using national
distributors.
|
